CLARIVATE PLC (CLVT) earnings date
Feb 24, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 30 days, typically, give or take 11 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Tue, Nov 3, 2026 | before open | 34 | 8-K |
| Q2 FY2026 | Wed, Jul 29, 2026 | before open | 29 | 8-K |
| Q1 FY2026 | Wed, Apr 29, 2026 | before open | 29 | 8-K |
| Q4 FY2025 | Tue, Feb 24, 2026 | before open | 55 | 8-K |
| Q3 FY2025 | Wed, Oct 29, 2025 | before open | 29 | 8-K |
| Q2 FY2025 | Wed, Jul 30, 2025 | before open | 30 | 8-K |
| Q1 FY2025 | Tue, Apr 29, 2025 | before open | 29 | 8-K |
| Q4 FY2024 | Wed, Feb 19, 2025 | before open | 50 | 8-K |
What they guided beta
| Q3 FY2026 | "EX-99.1 2 ex991q32026earningsrelease.htm EX-99.1 Ex. 99.1 Q3 2026 Earnings Release 1 Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation — Improved recurring organic revenue growth driven by portfolio transformation and AI-led innovation — — Updates 2026 financial outlook following the divestiture of Life Sciences & Healthcare segment — London, UK -- November 3, 2026 Clarivate Plc (NYSE: CLVT) (the “Company” or “Clarivate”), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2026 ." exhibit |
| Q3 FY2026 | "Organic revenues for continuing operations increased 0.1% , as a 0.9% increase in organic recurring revenues (subscription and re-occurring) was offset by lower organic transactional revenues. 2 Net loss , including LS&H, was $389.6 million , or $0.61 per diluted share, compared to a net loss of $204.2 million , or $0.30 per diluted share, for the first nine months of 2025 , driven by a $283.9 million non-cash LS&H goodwill impairment charge ." exhibit |
| Q3 FY2026 | "Updates 2026 outlook excluding discontinued operations (forward-looking statement) The full year 2026 outlook presented below assumes no further acquisitions, divestitures, or unanticipated events." exhibit |
| Q3 FY2026 | "The Q4 2026 outlook presented below is provided in connection with the completion of the LS&H divestiture and also assumes no further acquisitions, divestitures, or unanticipated events." exhibit |
| Q3 FY2026 | "Full Year 2026 Outlook Q4 2026 Outlook ACV Organic Growth 1.75% to 2.25% 1.75% to 2.25% Recurring Organic Revenue Growth 1.00% to 1.50% 2.00% to 2.50% Revenues $1.965B to $1.985B $490M to $510M Adjusted EBITDA (1) $0.865B to $0.885B $215M to $235M Adjusted EBITDA Margin (1) 43.0% to 45.0% 44.0% to 46.0% Adjusted Diluted EPS (1)(2) $0.73 to $0.77 $0.14 to $0.18 Free Cash Flow (1)(3) $320M to $340M $85M to $105M Notes to press release (1) Non-GAAP measure." exhibit |
| Q2 FY2026 | "EX-99.1 2 ex991q22026earningsrelease.htm EX-99.1 Ex. 99.1 Q2 2026 Earnings Release 1 Clarivate Reports Second Quarter 2026 Results — Delivers continued progress on strategic and financial priorities through Value Creation Plan — — Sharpens focus and enhances financial profile with previously announced Life Sciences & Healthcare segment divestiture — — Reaffirms 2026 financial outlook — London, UK -- July 29, 2026 Clarivate Plc (NYSE: CLVT) (the “Company” or “Clarivate”), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 202" exhibit |
| Q2 FY2026 | "Free cash flow for the first six months of 2026 was $122.9 million compared to $160.6 million in the prior year period. 3 Reaffirms outlook for 2026 (forward-looking statement) The full year outlook presented below assumes no further acquisitions, divestitures, or unanticipated events." exhibit |
| Q2 FY2026 | "Full Year 2026 Outlook ACV Organic Growth 2.0% to 3.0% Recurring Organic Revenue Growth 0.75% to 2.25% Revenues, Including Discontinued Operations (1) $2.30B to $2.42B Adjusted EBITDA (1) $980M to $1.04B Adjusted EBITDA Margin (1) 42.0% to 43.5% Adjusted Diluted EPS (1)(2) $0.70 to $0.80 Free Cash Flow (1) $365M to $435M Notes to press release (1) Non-GAAP measure." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CLVT
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CLVT
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/CLVT/"><img src="https://veritasdata.dev/embed/CLVT.svg" alt="CLVT earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/CLVT/)
Script
<script async src="https://veritasdata.dev/embed/CLVT.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CLVT"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.